Soleno Therapeutics Inc Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 3.00M-4.13M0.61M1.45M-0.23M
Cost of Revenue 0.25M1.74M1.51M0.03M
Gross Profit 3.00M-4.13M0.25M-0.06M-0.23M
Operating items
Research & Development 2.38M2.24M4.54M2.25M3.07M7.18M15.27M25.19M78.57M
Selling, General & Administrative 1.47M2.67M6.14M6.08M6.58M6.56M9.84M13.48M105.86M
Other Operating Expenses 0.25M1.74M-0.09M0.00M0.01M-0.71M2.71M3.24M
Operating Expenses 3.85M5.16M12.41M8.32M12.17M14.30M24.40M41.38M187.67M
Operating Income -0.85M-5.16M-12.16M-8.32M-12.17M-14.30M-24.40M-41.38M-187.67M
EBIT -0.85M-5.16M-12.16M-8.32M-12.17M-14.30M-24.40M-41.38M-187.67M
Non-operating items
Interest & Investment Income 0.00M0.00M0.30M2.58M12.05M
Other Non Operating Income -0.00M-4.59M-3.75M1.59M-0.59M-0.06M
Non Operating Income -0.00M-4.59M-3.75M1.59M-1.27M2.46M0.33M2.40M11.82M
Net income details
EBT -3.71M-9.29M-15.91M-6.74M-13.44M-11.84M-24.10M-38.81M-175.85M
Tax Provisions -1.65M
Profit After Tax -3.71M-13.24M-15.91M-12.07M-15.38M-13.34M-24.07M-38.99M-175.90M
Income from Continuing Operations -3.71M-9.29M-15.91M-6.74M-11.79M-11.84M-24.10M-38.81M-175.85M
Consolidated Net Income -3.71M-9.29M-15.91M-5.33M-3.59M-1.49M-24.10M-38.81M-175.85M
Income towards Parent Company -3.71M-9.29M-15.91M-5.33M-3.59M-1.49M-24.10M-38.81M-175.85M
Preferred Dividend Payments 3.65M
Net Income towards Common Stockholders -3.71M-9.29M-15.91M-15.72M-15.67M-1.49M-24.10M-38.81M-175.85M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.09M0.16M0.21M0.67M1.43M2.98M5.31M5.32M8.16M30.50M43.12M
EBITDA -0.85M-5.16M-12.16M-8.32M-12.17M-14.30M-24.07M-38.99M-175.49M
Tax Rate 12.27%